Oct 2, 2020 | Clinical Study, News
Equine Amnio Solutions, LLC (EAS), a distributor of advanced, next-generation equine regenerative products, announced today initiation of a new study evaluating use of the RenoVō® allograft in equine joints. The study, entitled “Effects of intra-articular injection of...
Oct 2, 2020 | Event, News
Equine Amnio Solutions, LLC (EAS), a distributor of advanced, next-generation equine regenerative products, announced today that several of its sponsored riders have qualified for the Wrangler® National Finals Rodeo (NFR) 2020. This year’s event will take place in...
Jun 30, 2020 | Clinical Study, Event, News
Equine Amnio Solutions, LLC (EAS), a distributor of advanced, next-generation regenerative products derived from amniotic birth tissues, announced today first results from a large field study of RenoVō® for soft tissue and orthopedic horse injuries. RenoVō® is an...
May 28, 2020 | Clinical Study, News
Senner and his co-founder, COO and Chief Scientific Officer, Christian Beaudry, saw a need to bring regenerative medicine to the equine world. They found the opportunity to take existing technologies and successfully apply them to the emerging branch of veterinary...
Oct 5, 2019 | Clinical Study, News
Equine Amnio Solutions, LLC (EAS), a distributor of advanced equine allografts derived from equine amniotic tissues, announced today partnership with the Oklahoma State University College of Veterinary Medicine to conduct clinical evaluation of RenoVō® on equine limb...
